Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-28 Sale |
2022-03-02 9:10 pm |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell SVP, CCO |
13,184 | $2.1629 | $28,515 | 373,841 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-01 8:35 pm |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell SVP, CCO |
952 | $3.4 | $3,237 | 137,025 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-02 4:08 pm |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell CCO |
6,749 | $3.3961 | $22,920 | 238,825 (Direct) |
View |
| 2020-06-01 Sale |
2020-06-02 4:34 pm |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell CCO |
6,426 | $11.58 | $74,413 | 73,574 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-28 Option Award |
2022-03-02 9:10 pm |
N/A 2032-02-28 |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell SVP, CCO |
250,000 | $0 | 373,841 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:18 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell CCO |
9,152 | $0 | 137,977 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:08 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Faulkingham Dell CCO |
172,000 | $0 | 238,825 (Direct) |
View |